SCHEMBL7982128

SCHEMBL7982128

Clc1cccc(Cl)c1Nc1nc2ccccc2n2cncc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969709 0.91 LCK (1.00) LCK
SCHEMBL7980228 0.90 LCK (0.81) LCK
SCHEMBL7979866 0.86 LCK (1.00) LCK
SCHEMBL7969592 0.86 LCK (0.83) LCK
SCHEMBL7980884 0.84 LCK (1.00) LCK
SCHEMBL7980767 0.84 LCK (1.00) LCK
SCHEMBL7984724 0.84 LCK (1.00) LCK
SCHEMBL7983379 0.84 LCK (0.85) LCK
SCHEMBL7979903 0.82 LCK (0.70) LCK
SCHEMBL7987291 0.82 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed